Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Cell Rep ; 38(11): 110532, 2022 03 15.
Artículo en Inglés | MEDLINE | ID: mdl-35294881

RESUMEN

Major depressive disorder is a complex disease resulting from aberrant synaptic plasticity that may be caused by abnormal serotonergic signaling. Using a combination of behavioral, biochemical, and imaging methods, we analyze 5-HT7R/MMP-9 signaling and dendritic spine plasticity in the hippocampus in mice treated with the selective 5-HT7R agonist (LP-211) and in a model of chronic unpredictable stress (CUS)-induced depressive-like behavior. We show that acute 5-HT7R activation induces depressive-like behavior in mice in an MMP-9-dependent manner and that post mortem brain samples from human individuals with depression reveal increased MMP-9 enzymatic activity in the hippocampus. Both pharmacological activation of 5-HT7R and modulation of its downstream effectors as a result of CUS lead to dendritic spine elongation and decreased spine density in this region. Overall, the 5-HT7R/MMP-9 pathway is specifically activated in the CA1 subregion of the hippocampus during chronic stress and is crucial for inducing depressive-like behavior.


Asunto(s)
Región CA1 Hipocampal , Trastorno Depresivo Mayor , Animales , Región CA1 Hipocampal/metabolismo , Trastorno Depresivo Mayor/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Receptores de Serotonina/metabolismo
2.
Glia ; 69(4): 872-889, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33156956

RESUMEN

Astrocytes are an important component of the multipartite synapse and crucial for proper neuronal network function. Although small GTPases of the Rho family are powerful regulators of cellular morphology, the signaling modules of Rho-mediated pathways in astrocytes remain enigmatic. Here we demonstrated that the serotonin receptor 4 (5-HT4 R) is expressed in hippocampal astrocytes, both in vitro and in vivo. Through fluorescence microscopy, we established that 5-HT4 R activation triggered RhoA activity via Gα13 -mediated signaling, which boosted filamentous actin assembly, leading to morphological changes in hippocampal astrocytes. We investigated the effects of these 5-HT4 R-mediated changes in mixed cultures and in acute slices, in which 5-HT4 R was expressed exclusively in astrocytes. In both systems, 5-HT4 R-RhoA signaling changed glutamatergic synaptic transmission: It increased the frequency of miniature excitatory postsynaptic currents (mEPSCs) in mixed cultures and reduced the paired-pulse-ratio (PPR) of field excitatory postsynaptic potentials (fEPSPs) in acute slices. Overall, our present findings demonstrate that astrocytic 5-HT4 R-Gα13 -RhoA signaling is a previously unrecognized molecular pathway involved in the functional regulation of excitatory synaptic circuits.


Asunto(s)
Astrocitos , Serotonina , Potenciales Postsinápticos Excitadores , Hipocampo , Receptores de Serotonina/genética , Transmisión Sináptica
3.
Int J Mol Sci ; 20(7)2019 Apr 08.
Artículo en Inglés | MEDLINE | ID: mdl-30965559

RESUMEN

Ketamine is an N-methyl-d-aspartate receptor antagonist that has gained wide attention as a potent antidepressant. It has also been recently reported to have prophylactic effects in animal models of depression and anxiety. Alterations of neuroplasticity in different brain regions; such as the hippocampus; prefrontal cortex; and amygdala; are a hallmark of stress-related disorders; and such changes may endure beyond the treatment of symptoms. The present study investigated whether a prophylactic injection of ketamine has effects on structural plasticity in the brain in mice that are subjected to chronic unpredictable stress followed by an 8-day recovery period. Ketamine administration (3 mg/kg body weight) 1 h before stress exposure increased the number of resilient animals immediately after the cessation of stress exposure and positively influenced the recovery of susceptible animals to hedonic deficits. At the end of the recovery period; ketamine-treated animals exhibited significant differences in dendritic spine density and dendritic spine morphology in brain regions associated with depression compared with saline-treated animals. These results confirm previous findings of the prophylactic effects of ketamine and provide further evidence of an association between the antidepressant-like effect of ketamine and alterations of structural plasticity in the brain.


Asunto(s)
Antidepresivos/uso terapéutico , Región CA3 Hipocampal/efectos de los fármacos , Depresión/tratamiento farmacológico , Hipocampo/efectos de los fármacos , Ketamina/uso terapéutico , Plasticidad Neuronal/efectos de los fármacos , Estrés Fisiológico/efectos de los fármacos , Animales , Conducta Animal , Depresión/patología , Modelos Animales de Enfermedad , Suspensión Trasera/fisiología , Hipocampo/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Restricción Física/fisiología , Estrés Psicológico/tratamiento farmacológico , Estrés Psicológico/patología
4.
Neurosci Biobehav Rev ; 99: 101-116, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30529362

RESUMEN

Depression is currently among the top five leading causes of the global burden of disease. Chronic unpredictable mild stress (CUMS) is currently the most commonly used, reliable, and effective rodent model of depression. However, for unclear reasons, this protocol is often difficult to reproduce in different laboratories. We performed a meta-analysis of studies that used the CUMS paradigm to evaluate depressive-like behavior in rodents. We sought to identify strain-dependent susceptibility to stress based on the development of one of the main end points of the model, "anhedonia." The meta-analysis indicated that the CUMS protocol is a robust animal model of depression and is strongly associated with anhedonic behavior in rodents. However, high heterogeneity was found in the single subgroup analysis, which was attributable to modification of the CUMS and sucrose preference protocols. This may explain difficulties in reproducing stress protocols by different research groups.


Asunto(s)
Antidepresivos/uso terapéutico , Conducta Animal/efectos de los fármacos , Depresión/tratamiento farmacológico , Trastorno Depresivo/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Humanos , Estrés Psicológico/complicaciones , Estrés Psicológico/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...